HBHannah Beauseroy

Hannah Beauseroy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hannah Beauseroy has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Aqueous ring-opening polymerization-induced self-assembly of N-carboxyanhydrides towards nanomedicine

    by Hannah Beauseroy

    Auto-assemblage induit par polymérisation par ouverture de cycle des N-carboxyanhydrides en milieux aqueux vers une application en nanomédecine: Les copolymères à blocs amphiphiles permettent de concevoir des nanovecteurs aux propriétés contrôlées (taille, forme, surface), capables de cibler les tumeurs via l’effet de perméabilité et de rétention accrue (EPR) tout en limitant la toxicité des traitements. Les systèmes à base de polypeptides sont particulièrement prometteurs grâce à leur biocompatibilité, leur biodégradabilité et leur capacité à s’auto-assembler via des structures secondaires bien définies. La polymérisation par ouverture de cycle (ROP) des N-carboxyanhydrides (NCA) permet d’obtenir ces matériaux, mais impose des conditions rigoureuses et l’usage de solvants toxiques. Le procédé ROPISA en milieu aqueux représente une alternative plus verte, combinant polymérisation et auto-assemblage en une étape. Cette thèse explore les mécanismes de la ROPISA aqueuse, la diversité des monomères et amorceurs utilisables, et la manière dont ces paramètres influencent les morphologies obtenues. Des nanoparticules anisotropes ont été produites et évaluées in vitro et in vivo sur des modèles tumoraux pertinents. Enfin, des stratégies d'encapsulation de principes actifs ont été développées pour concevoir des nanomédicaments anticancéreux.

  • Open Access

    Polypeptide-based nanocarriers from aqueous ROPISA: Shape-dependent performance in colorectal and breast cancer models

    by Hannah Beauseroy, Sabina Quader, Xueying Liu, Colin Bonduelle, Kazunori Kataoka, Sébastien Lecommandoux


  • Open Access

    In Situ Synthesis of Degradable Polymer Prodrug Nanoparticles

    by Chen Zhu, Hannah Beauseroy, Julie Mougin, Maëlle Lages, Julien Nicolas

    The in-situ synthesis of degradable polymer prodrug nanoparticles is still a challenge to be met, which would make it possible to remedy both the shortcomings of traditional formulation of preformed polymers (e.g., low nanoparticle concentrations) and those of the physical encapsulation of drugs (e.g., burst release, poor drug loadings). Herein, by the combination of radical ring-opening polymerization (rROP) and polymerization-induced self-assembly (PISA) under appropriate experimental conditions, we report the successful preparation of high solid contents, degradable polymer prodrug nanoparticles, exhibiting multiple drug moieties covalently linked to a degradable vinyl copolymer backbone. Such rROPISA process relied on a chain extension of a biocompatible poly(ethylene glycol)-based solvophilic block with a mixture of lauryl methacrylate (LMA), cyclic ketene acetal (CKA) and drug-bearing methacrylic esters by reversible addition fragmentation chain transfer (RAFT) copolymerization at 20 wt % solids content. This novel approach was exemplified with two different CKA monomers and two different anticancer drugs, namely paclitaxel and gemcitabine, to demonstrate its versatility. After transferring to water, remarkably stable aqueous suspensions of core-degradable polymer prodrug nanoparticles of 56-225 nm in diameter with tunable amounts of CKA units (7-26 mol.%) and drug loadings up to 33 wt % were obtained. Incorporation of ester groups in the copolymers was demonstrated by hydrolytic degradation of both the copolymers and the nanoparticles under accelerated conditions. The nanoparticles showed significant cytotoxicity on A549 cells, used as a lung cancer model. Fluorescence labeling of the solvophilic block also enabled effective monitoring of their cell internalization by confocal microscopy, with the potential for theranostic applications.